Filing Details
- Accession Number:
- 0001209191-14-064299
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-10-22 16:15:43
- Reporting Period:
- 2014-10-20
- Filing Date:
- 2014-10-22
- Accepted Time:
- 2014-10-22 16:15:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1037760 | Cepheid | CPHD | Laboratory Analytical Instruments (3826) | 770441625 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1187333 | Hollings Renton | C/O Cepheid 904 Caribbean Drive Sunnyvale CA 94089 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-10-20 | 12,500 | $0.00 | 22,017 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-10-20 | 11,900 | $45.83 | 10,117 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-10-20 | 600 | $46.32 | 9,517 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2014-10-20 | 12,500 | $0.00 | 12,500 | $19.85 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2009-04-24 | 2015-04-24 | No | 4 | M | Direct |
Footnotes
- The sales price reported is the weighted average sale price for the number of shares sold. Full information regarding the number of shares sold at each separate price will be supplied upon request by the Securities & Exchange Commission staff, the Issuer or a security holder of the Issuer.
- 100% of the shares vested and became exercisable one year from the date of grant.
Billionaire Hedge Funds
